<?xml version="1.0" encoding="UTF-8"?>
<html lang="en" dir="ltr" xmlns="http://www.w3.org/1999/xhtml">
 <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#"> 
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> 
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes"/>
  <meta name="article_thumbnail" content="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711/embed/graphic-3.gif"/>
  <meta name="type" content="article"/>
  <meta name="category" content="article"/>
  <meta name="HW.identifier" content="/biorxiv/early/2020/03/17/2020.03.10.986711.atom"/>
  <meta name="HW.pisa" content="biorxiv;2020.03.10.986711v1"/>
  <meta name="DC.Format" content="text/html"/>
  <meta name="DC.Language" content="en"/>
  <meta name="DC.Title" content="Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols"/>
  <meta name="DC.Identifier" content="10.1101/2020.03.10.986711"/>
  <meta name="DC.Date" content="2020-03-17"/>
  <meta name="DC.Publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="DC.Rights" content="© 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/"/>
  <meta name="DC.AccessRights" content="restricted"/>
  <meta name="DC.Description" content="The recent emergence of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19 is a major burden for health care systems worldwide. It is important to address if the current infection control instructions based on active ingredients are sufficient. We therefore determined the virucidal activity of two alcohol-based hand rub solutions for hand disinfection recommended by the World Health Organization (WHO), as well as commercially available alcohols. Efficient SARS-CoV-2 inactivation was demonstrated for all tested alcohol-based disinfectants. These findings show the successful inactivation of SARS-CoV-2 for the first time and provide confidence in its use for the control of COVID-19. Importance The current COVID-19 outbreak puts a huge burden on the world’s health care systems. Without effective therapeutics or vaccines being available, effective hygiene measure are of utmost importance to prevent viral spreading. It is therefore crucial to evaluate current infection control strategies against SARS-CoV-2. We show the inactivation of the novel coronavirus for the first time and endorse the importance of disinfectant-based hand hygiene to reduce SARS-CoV-2 transmission."/>
  <meta name="DC.Contributor" content="Annika Kratzel"/>
  <meta name="DC.Contributor" content="Daniel Todt"/>
  <meta name="DC.Contributor" content="Philip V’kovski"/>
  <meta name="DC.Contributor" content="Silvio Steiner"/>
  <meta name="DC.Contributor" content="Mitra L. Gultom"/>
  <meta name="DC.Contributor" content="Tran Thi Nhu Thao"/>
  <meta name="DC.Contributor" content="Nadine Ebert"/>
  <meta name="DC.Contributor" content="Melle Holwerda"/>
  <meta name="DC.Contributor" content="Jörg Steinmann"/>
  <meta name="DC.Contributor" content="Daniela Niemeyer"/>
  <meta name="DC.Contributor" content="Ronald Dijkman"/>
  <meta name="DC.Contributor" content="Günter Kampf"/>
  <meta name="DC.Contributor" content="Christian Drosten"/>
  <meta name="DC.Contributor" content="Eike Steinmann"/>
  <meta name="DC.Contributor" content="Volker Thiel"/>
  <meta name="DC.Contributor" content="Stephanie Pfaender"/>
  <meta name="article:published_time" content="2020-03-17"/>
  <meta name="article:section" content="New Results"/>
  <meta name="citation_title" content="Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols"/>
  <meta name="citation_abstract" lang="en" content="&lt;;p&gt;;The recent emergence of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19 is a major burden for health care systems worldwide. It is important to address if the current infection control instructions based on active ingredients are sufficient. We therefore determined the virucidal activity of two alcohol-based hand rub solutions for hand disinfection recommended by the World Health Organization (WHO), as well as commercially available alcohols. Efficient SARS-CoV-2 inactivation was demonstrated for all tested alcohol-based disinfectants. These findings show the successful inactivation of SARS-CoV-2 for the first time and provide confidence in its use for the control of COVID-19.&lt;;/p&gt;;"/>
  <meta name="citation_journal_title" content="bioRxiv"/>
  <meta name="citation_publisher" content="Cold Spring Harbor Laboratory"/>
  <meta name="citation_publication_date" content="2020/01/01"/>
  <meta name="citation_mjid" content="biorxiv;2020.03.10.986711v1"/>
  <meta name="citation_id" content="2020.03.10.986711v1"/>
  <meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/2020.03.10.986711v1"/>
  <meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/2020.03.10.986711v1.abstract"/>
  <meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/2020.03.10.986711v1.full"/>
  <meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711.full.pdf"/>
  <meta name="citation_doi" content="10.1101/2020.03.10.986711"/>
  <meta name="citation_num_pages" content="13"/>
  <meta name="citation_article_type" content="Article"/>
  <meta name="citation_section" content="New Results"/>
  <meta name="citation_firstpage" content="2020.03.10.986711"/>
  <meta name="citation_author" content="Annika Kratzel"/>
  <meta name="citation_author_institution" content="Institute of Virology and Immunology"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern"/>
  <meta name="citation_author_institution" content="Graduate School for Cellular and Biomedical Sciences, University of Bern"/>
  <meta name="citation_author" content="Daniel Todt"/>
  <meta name="citation_author_institution" content="Department for Molecular &amp;; Medical Virology, Ruhr-Universität Bochum"/>
  <meta name="citation_author" content="Philip V’kovski"/>
  <meta name="citation_author_institution" content="Institute of Virology and Immunology"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern"/>
  <meta name="citation_author" content="Silvio Steiner"/>
  <meta name="citation_author_institution" content="Institute of Virology and Immunology"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern"/>
  <meta name="citation_author_institution" content="Graduate School for Cellular and Biomedical Sciences, University of Bern"/>
  <meta name="citation_author" content="Mitra L. Gultom"/>
  <meta name="citation_author_institution" content="Institute of Virology and Immunology"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern"/>
  <meta name="citation_author_institution" content="Graduate School for Cellular and Biomedical Sciences, University of Bern"/>
  <meta name="citation_author" content="Tran Thi Nhu Thao"/>
  <meta name="citation_author_institution" content="Institute of Virology and Immunology"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern"/>
  <meta name="citation_author_institution" content="Graduate School for Cellular and Biomedical Sciences, University of Bern"/>
  <meta name="citation_author" content="Nadine Ebert"/>
  <meta name="citation_author_institution" content="Institute of Virology and Immunology"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern"/>
  <meta name="citation_author" content="Melle Holwerda"/>
  <meta name="citation_author_institution" content="Institute of Virology and Immunology"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern"/>
  <meta name="citation_author_institution" content="Graduate School for Cellular and Biomedical Sciences, University of Bern"/>
  <meta name="citation_author_institution" content="Institute for Infectious Diseases, University of Bern"/>
  <meta name="citation_author" content="Jörg Steinmann"/>
  <meta name="citation_author_institution" content="Institute of Medical Microbiology, University Hospital of Essen"/>
  <meta name="citation_author_institution" content="Institute of Clinical Hygiene, Medical Microbiology and Infectiology, General Hospital Nürnberg, Paracelsus Medical University"/>
  <meta name="citation_author" content="Daniela Niemeyer"/>
  <meta name="citation_author_institution" content="Institute of Virology, Charité Berlin"/>
  <meta name="citation_author" content="Ronald Dijkman"/>
  <meta name="citation_author_institution" content="Institute of Virology and Immunology"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern"/>
  <meta name="citation_author_institution" content="Institute for Infectious Diseases, University of Bern"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0003-0320-2743"/>
  <meta name="citation_author" content="Günter Kampf"/>
  <meta name="citation_author_institution" content="University Medicine Greifswald, Institute for Hygiene and Environmental Medicine"/>
  <meta name="citation_author" content="Christian Drosten"/>
  <meta name="citation_author_institution" content="Institute of Virology, Charité Berlin"/>
  <meta name="citation_author" content="Eike Steinmann"/>
  <meta name="citation_author_institution" content="Department for Molecular &amp;; Medical Virology, Ruhr-Universität Bochum"/>
  <meta name="citation_author" content="Volker Thiel"/>
  <meta name="citation_author_institution" content="Institute of Virology and Immunology"/>
  <meta name="citation_author_institution" content="Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern"/>
  <meta name="citation_author" content="Stephanie Pfaender"/>
  <meta name="citation_author_institution" content="Department for Molecular &amp;; Medical Virology, Ruhr-Universität Bochum"/>
  <meta name="citation_author_email" content="stephanie.pfaender@ruhr-uni-bochum.de"/>
  <meta name="citation_reference" content="Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1967–1976. doi:10.1056/NEJMoa030747"/>
  <meta name="citation_reference" content="Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus ADME, Fouchier RAM. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. N Engl JMed. 2012;367(19):1814–1820. doi:10.1056/NEJMoa1211721"/>
  <meta name="citation_reference" content="WHO(b). WHO Guidelines on Hand Hygiene in Health Care. World Health. 2009;30(1):270. doi:10.1086/600379"/>
  <meta name="citation_reference" content="Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsueh P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020:105924. doi:10.1016/j.ijantimicag.2020.105924"/>
  <meta name="citation_reference" content="CSSE Johns Hopkins. Coronavirus COVID-19 Global Cases."/>
  <meta name="citation_reference" content="Siddharta A, Pfaender S, Vielle NJ, et al. Virucidal activity of world health organization-recommended formulations against enveloped viruses, including zika, ebola, and emerging coronaviruses. J Infect Dis. 2017;215(6):902–906. doi:10.1093/infdis/jix046"/>
  <meta name="citation_reference" content="Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hosp Infect. 2020. doi:10.1016/j.jhin.2020.01.022"/>
  <meta name="citation_reference" content="Becker B, Brill FHH, Todt D, et al. Virucidal efficacy of peracetic acid for instrument disinfection. Antimicrob Resist Infect Control. 2017;6(1). doi:10.1186/s13756-017-0271-3"/>
  <meta name="citation_reference" content="Places G, Hierholzer JC, Killington RA. Cell Culture Cell Culture. Virol Methods Man. 1996;76(1):2–6. doi:10.1016/B978-012465330-6/50003-8"/>
  <meta name="twitter:title" content="Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols"/>
  <meta name="twitter:site" content="@biorxivpreprint"/>
  <meta name="twitter:card" content="summary"/>
  <meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="twitter:description" content="The recent emergence of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19 is a major burden for health care systems worldwide. It is important to address if the current infection control instructions based on active ingredients are sufficient. We therefore determined the virucidal activity of two alcohol-based hand rub solutions for hand disinfection recommended by the World Health Organization (WHO), as well as commercially available alcohols. Efficient SARS-CoV-2 inactivation was demonstrated for all tested alcohol-based disinfectants. These findings show the successful inactivation of SARS-CoV-2 for the first time and provide confidence in its use for the control of COVID-19. Importance The current COVID-19 outbreak puts a huge burden on the world’s health care systems. Without effective therapeutics or vaccines being available, effective hygiene measure are of utmost importance to prevent viral spreading. It is therefore crucial to evaluate current infection control strategies against SARS-CoV-2. We show the inactivation of the novel coronavirus for the first time and endorse the importance of disinfectant-based hand hygiene to reduce SARS-CoV-2 transmission."/>
  <meta name="og-title" property="og:title" content="Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols"/>
  <meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/2020.03.10.986711v1"/>
  <meta name="og-site-name" property="og:site_name" content="bioRxiv"/>
  <meta name="og-description" property="og:description" content="The recent emergence of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19 is a major burden for health care systems worldwide. It is important to address if the current infection control instructions based on active ingredients are sufficient. We therefore determined the virucidal activity of two alcohol-based hand rub solutions for hand disinfection recommended by the World Health Organization (WHO), as well as commercially available alcohols. Efficient SARS-CoV-2 inactivation was demonstrated for all tested alcohol-based disinfectants. These findings show the successful inactivation of SARS-CoV-2 for the first time and provide confidence in its use for the control of COVID-19. Importance The current COVID-19 outbreak puts a huge burden on the world’s health care systems. Without effective therapeutics or vaccines being available, effective hygiene measure are of utmost importance to prevent viral spreading. It is therefore crucial to evaluate current infection control strategies against SARS-CoV-2. We show the inactivation of the novel coronavirus for the first time and endorse the importance of disinfectant-based hand hygiene to reduce SARS-CoV-2 transmission."/>
  <meta name="og-type" property="og:type" content="article"/>
  <meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png"/>
  <meta name="citation_date" content="2020-03-17"/> 
  <meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution"/>
  <meta name="generator" content="Drupal 7 (http://drupal.org)"/> 
  <title>Efficient inactivation of SARS-CoV-2 by WHO-recommended hand rub formulations and alcohols | bioRxiv</title> 
 </head>
 <body class="html not-front not-logged-in page-node page-node- page-node-1199905 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-type-article hw-article-category-new-results"> 
  <div class="article fulltext-view ">
   <span class="highwire-journal-article-marker-start"/>
   <div class="section abstract" id="abstract-1">
    <h2 class="">Abstract</h2>
    <p id="p-4">The recent emergence of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19 is a major burden for health care systems worldwide. It is important to address if the current infection control instructions based on active ingredients are sufficient. We therefore determined the virucidal activity of two alcohol-based hand rub solutions for hand disinfection recommended by the World Health Organization (WHO), as well as commercially available alcohols. Efficient SARS-CoV-2 inactivation was demonstrated for all tested alcohol-based disinfectants. These findings show the successful inactivation of SARS-CoV-2 for the first time and provide confidence in its use for the control of COVID-19.</p>
    <div id="sec-1" class="subsection">
     <p id="p-5">
      <strong>Importance</strong> The current COVID-19 outbreak puts a huge burden on the world’s health care systems. Without effective therapeutics or vaccines being available, effective hygiene measure are of utmost importance to prevent viral spreading. It is therefore crucial to evaluate current infection control strategies against SARS-CoV-2. We show the inactivation of the novel coronavirus for the first time and endorse the importance of disinfectant-based hand hygiene to reduce SARS-CoV-2 transmission.
     </p>
    </div>
   </div>
   <div class="section" id="sec-2">
    <h2 class="">Introduction</h2>
    <p id="p-6">SARS-CoV-2 is the third highly pathogenic human CoV to have crossed the species barrier into humans during the last 20 years
     <sup>
      <a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>,
      <a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>,
      <a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>
     </sup>. SARS-CoV-2 infection is associated with coronavirus disease 2019 (COVID-19) which is characterized by severe respiratory distress, fever and cough, leading to a high percentage of fatalities, especially in the elderly or patients with comorbidities
     <sup>
      <a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>
     </sup>. As of March 6
     <sup>th</sup> 2020 there are 101604 globally confirmed cases and related 3460 deaths
     <sup>
      <a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>
     </sup>. Health care experts suspect that a global pandemic is inevitable mainly because human-to-human transmission of SARS-CoV-2 is very efficient and infected individuals can transmit the virus without or with only mild symptoms
     <sup>
      <a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">4</a>
     </sup>. Given that so far, no therapeutics or vaccines are available, virus containment and prevention of infection are of highest priority. Effective hand hygiene is crucial to limit virus spread. Therefore, easily available but efficient disinfectants are crucial. The World Health Organization’s ‘Guidelines for Hand Hygiene in Health Care’ suggests two alcohol-based formulations for hand sanitization to reduce pathogen infectivity and spreading. These recommendations are based on fast-acting and broad-spectrum of microbicidal activity, as well as easy accessibility and safety
     <sup>
      <a id="xref-ref-3-2" class="xref-bibr" href="#ref-3">3</a>
     </sup>. We have previously shown that WHO formulation I and II were able to inactivate the closely related SARS-CoV and MERS-CoV
     <sup>
      <a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>
     </sup>. So far, recommendations to inactivate SARS-CoV-2 were only translated from findings with other coronaviruses
     <sup>
      <a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>
     </sup>. To evaluate if alcohol-based disinfectants are also efficient for the inactivation of SARS-CoV-2, we tested different concentrations of WHO formulation I and II, as well as the alcohols ethanol and 2-propanol for their virucidal activity.
    </p>
   </div>
   <div class="section" id="sec-3">
    <h2 class="">Results</h2>
    <p id="p-7">SARS-CoV-2 was highly susceptible to the WHO formulations (
     <strong>
      <a id="xref-fig-1-1" class="xref-fig" href="#F1">Fig. 1</a>
     </strong>). WHO formulation I, based on 85 % ethanol, efficiently inactivated the virus with reduction factors (RFs) of ≤ 5.9 and concentrations between 40 % – 80 % (
     <strong>
      <a id="xref-fig-1-2" class="xref-fig" href="#F1">Fig. 1A</a>
     </strong>). Subsequent regression analysis revealed similar inactivation profiles compared to SARS-CoV, MERS-CoV and bovine CoV (BCoV), which is often used as surrogate for highly pathogenic human CoVs (
     <strong>
      <a id="xref-fig-1-3" class="xref-fig" href="#F1">Fig. 1A</a>
     </strong>). WHO formulation II, which is based on 75 % isopropanol, demonstrated a better virucidal effect at low concentrations, with complete viral inactivation and RFs of ≤ 5 at a minimal concentration of 30 % (
     <strong>
      <a id="xref-fig-1-4" class="xref-fig" href="#F1">Fig. 1B</a>
     </strong>). The regression analysis showed an inactivation profile of SARS-CoV-2, which was in between SARS-CoV, BCoV and MERS-CoV 
     <strong>(
      <a id="xref-fig-1-5" class="xref-fig" href="#F1">Fig. 1B</a>)
     </strong>.
    </p>
    <div id="F1" class="fig pos-float type-figure odd">
     <div class="highwire-figure">
      <div class="fig-inline-img-wrapper">
       <div class="fig-inline-img">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711/F1.large.jpg?width=800&amp;;height=600&amp;;carousel=1" title="Virucidal activity of WHO formulations I (85 % ethanol) and II (75 % 2-propanol) against SARS-CoV-2. WHO formulations I (A) and II (B) were tested for their efficacy in inactivating SARS-CoV-2. The concentrations of the WHO formulations ranged from 0 % to 80 % with an exposure time of 30 seconds. Viral titers are displayed as 50 % tissue culture infectious dose 50 (TCID50/mL) values. Cytotoxic effects are displayed as dashed bars are and were calculated analogous to virus infectivity. RFs are included above the bar. The mean of two - three independent experiments with standard deviation are shown. LLOQ: lower limit of quantification. Top inserts: Regression analysis of the inactivation of SARS-CoV-2, bovine CoV (BCoV), SARS-CoV and MERS-CoV by WHO formulation I (A) and II (B). Depicted is the percentage of inactivation at different concentrations." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-579603472" data-figure-caption="&lt;;div class=&quot;;highwire-markup&quot;;&gt;;&lt;;div xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;;&gt;;&lt;;span class=&quot;;caption-title&quot;;&gt;;Virucidal activity of WHO formulations I (85 % ethanol) and II (75 % 2-propanol) against SARS-CoV-2.&lt;;/span&gt;; WHO formulations I (&lt;;strong&gt;;A&lt;;/strong&gt;;) and II (&lt;;strong&gt;;B&lt;;/strong&gt;;) were tested for their efficacy in inactivating SARS-CoV-2. The concentrations of the WHO formulations ranged from 0 % to 80 % with an exposure time of 30 seconds. Viral titers are displayed as 50 % tissue culture infectious dose 50 (TCID50/mL) values. Cytotoxic effects are displayed as dashed bars are and were calculated analogous to virus infectivity. RFs are included above the bar. The mean of two - three independent experiments with standard deviation are shown. LLOQ: lower limit of quantification. Top inserts: Regression analysis of the inactivation of SARS-CoV-2, bovine CoV (BCoV), SARS-CoV and MERS-CoV by WHO formulation I (&lt;;strong&gt;;A&lt;;/strong&gt;;) and II (&lt;;strong&gt;;B&lt;;/strong&gt;;). Depicted is the percentage of inactivation at different concentrations.&lt;;/div&gt;;&lt;;/div&gt;;" data-icon-position="" data-hide-link-title="0">
         <span class="hw-responsive-img">
          <img class="highwire-fragment fragment-image lazyload" alt="Figure 1" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711/F1.medium.gif" width="440" height="153"/>
          <noscript>
           <img class="highwire-fragment fragment-image" alt="Figure 1" src="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711/F1.medium.gif" width="440" height="153"/>
          </noscript>
         </span>
        </a>
       </div>
      </div>
      <ul class="highwire-figure-links inline">
       <li class="download-fig first">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 1" data-icon-position="" data-hide-link-title="0">Download figure</a>
       </li>
       <li class="new-tab last">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a>
       </li>
      </ul>
     </div>
     <div class="fig-caption">
      <span class="fig-label">Figure 1</span>
      <span class="caption-title">Virucidal activity of WHO formulations I (85 % ethanol) and II (75 % 2-propanol) against SARS-CoV-2.</span>
      <p id="p-8" class="first-child">WHO formulations I (
       <strong>A</strong>) and II (
       <strong>B</strong>) were tested for their efficacy in inactivating SARS-CoV-2. The concentrations of the WHO formulations ranged from 0 % to 80 % with an exposure time of 30 seconds. Viral titers are displayed as 50 % tissue culture infectious dose 50 (TCID50/mL) values. Cytotoxic effects are displayed as dashed bars are and were calculated analogous to virus infectivity. RFs are included above the bar. The mean of two - three independent experiments with standard deviation are shown. LLOQ: lower limit of quantification. Top inserts: Regression analysis of the inactivation of SARS-CoV-2, bovine CoV (BCoV), SARS-CoV and MERS-CoV by WHO formulation I (
       <strong>A</strong>) and II (
       <strong>B</strong>). Depicted is the percentage of inactivation at different concentrations.
      </p>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
    <p id="p-9">Next, we addressed the susceptibility of SARS-CoV-2 against the individual components of the WHO recommended formulations which are also the main ingredients of commercially available hand disinfections. Both alcohols, ethanol (
     <strong>
      <a id="xref-fig-2-1" class="xref-fig" href="#F2">Fig. 2A</a>
     </strong>) and 2-propanol (
     <strong>
      <a id="xref-fig-2-2" class="xref-fig" href="#F2">Fig. 2B</a>
     </strong>) were able to reduce viral titers in 30 s exposure to background levels with RFs between ≤ 4.8 and 5.9 after 30 sec. Furthermore, we could show that a minimal concentration of 30 % ethanol or 2-propanol is sufficient for viral inactivation (
     <strong>
      <a id="xref-fig-2-3" class="xref-fig" href="#F2">Fig. 2</a>
     </strong>).
    </p>
    <div id="F2" class="fig pos-float type-figure odd">
     <div class="highwire-figure">
      <div class="fig-inline-img-wrapper">
       <div class="fig-inline-img">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711/F2.large.jpg?width=800&amp;;height=600&amp;;carousel=1" title="Effect of alcohols on SARS-CoV-2. Commercially available ethanol (A), or 2-propanol (B) were tested for their efficacy in inactivating SARS-CoV-2. The biocide concentrations ranged from 0 % to 80 % with an exposure time of 30 seconds. Viral titers are displayed as 50 % tissue culture infectious dose 50 (TCID50/mL) values. Cytotoxic effects are displayed as dashed bars are and were calculated analogous to virus infectivity. LLOQ: lower limit of quantification. RFs are included above the bar. Dashed line: limit of detection. The mean of two - three independent experiments with standard deviation are shown." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-579603472" data-figure-caption="&lt;;div class=&quot;;highwire-markup&quot;;&gt;;&lt;;div xmlns=&quot;;http://www.w3.org/1999/xhtml&quot;;&gt;;&lt;;span class=&quot;;caption-title&quot;;&gt;;Effect of alcohols on SARS-CoV-2.&lt;;/span&gt;; Commercially available ethanol (&lt;;strong&gt;;A&lt;;/strong&gt;;), or 2-propanol (&lt;;strong&gt;;B&lt;;/strong&gt;;) were tested for their efficacy in inactivating SARS-CoV-2. The biocide concentrations ranged from 0 % to 80 % with an exposure time of 30 seconds. Viral titers are displayed as 50 % tissue culture infectious dose 50 (TCID&lt;;sub&gt;;50&lt;;/sub&gt;;/mL) values. Cytotoxic effects are displayed as dashed bars are and were calculated analogous to virus infectivity. LLOQ: lower limit of quantification. RFs are included above the bar. Dashed line: limit of detection. The mean of two - three independent experiments with standard deviation are shown.&lt;;/div&gt;;&lt;;/div&gt;;" data-icon-position="" data-hide-link-title="0">
         <span class="hw-responsive-img">
          <img class="highwire-fragment fragment-image lazyload" alt="Figure 2" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711/F2.medium.gif" width="440" height="164"/>
          <noscript>
           <img class="highwire-fragment fragment-image" alt="Figure 2" src="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711/F2.medium.gif" width="440" height="164"/>
          </noscript>
         </span>
        </a>
       </div>
      </div>
      <ul class="highwire-figure-links inline">
       <li class="download-fig first">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 2" data-icon-position="" data-hide-link-title="0">Download figure</a>
       </li>
       <li class="new-tab last">
        <a href="https://www.biorxiv.org/content/biorxiv/early/2020/03/17/2020.03.10.986711/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a>
       </li>
      </ul>
     </div>
     <div class="fig-caption">
      <span class="fig-label">Figure 2</span>
      <span class="caption-title">Effect of alcohols on SARS-CoV-2.</span>
      <p id="p-10" class="first-child">Commercially available ethanol (
       <strong>A</strong>), or 2-propanol (
       <strong>B</strong>) were tested for their efficacy in inactivating SARS-CoV-2. The biocide concentrations ranged from 0 % to 80 % with an exposure time of 30 seconds. Viral titers are displayed as 50 % tissue culture infectious dose 50 (TCID
       <sub>50</sub>/mL) values. Cytotoxic effects are displayed as dashed bars are and were calculated analogous to virus infectivity. LLOQ: lower limit of quantification. RFs are included above the bar. Dashed line: limit of detection. The mean of two - three independent experiments with standard deviation are shown.
      </p>
      <div class="sb-div caption-clear"/>
     </div>
    </div>
   </div>
   <div class="section" id="sec-4">
    <h2 class="">Discussions</h2>
    <p id="p-11">This study shows that SARS-CoV-2 can be efficiently inactivated by both WHO formulations implicating their use in health care systems and viral outbreak situations. Notably, both tested alcohols, ethanol and 2-propanol were efficient in inactivating the virus in 30 s at a minimal final concentration of at least 30 %. Alcohol constitutes the basis for many hand rubs routinely used in health care settings. Our findings are therefore of utmost importance in the current outbreak situation to minimize viral transmission and maximize virus inactivation.</p>
   </div>
   <div class="section" id="sec-5">
    <h2 class="">Material and Methods</h2>
    <div id="sec-6" class="subsection">
     <h3>Viral strains and cell culture</h3>
     <p id="p-12">SARS-CoV-2 (SARS-CoV-2/München-1.1/2020/929) stocks were propagated on VeroE6 cells (kindly provided by M-Müller/ C. Drosten, Charité, Berlin, Germany). VeroE6 cells were cultured in Dulbecco’s modified minimal essential medium (Gibco) supplemented with 10 % heat inactivated fetal bovine serum (Gibco), 1 % non-essential amino acids (Gibco), 100 μg/mL Streptomycin and 100 IU/mL Penicillin (Gibco) and 15 mM HEPES (Gibco).</p>
    </div>
    <div id="sec-7" class="subsection">
     <h3>Chemicals</h3>
     <p id="p-13">WHO I formulation consists of 85 % ethanol (v/v), 0.725 % glycerol (v/v) and 0.125 % hydrogen peroxide (v/v). The isopropyl-based formulation, WHO II, contains 75 % isopropanol (w/w), 0.725 % glycerol (v/v) and 0.125 % hydrogen peroxide (v/v)
      <sup>
       <a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>
      </sup>. In addition, ethanol (CAS 64-17-5), and 2-propanol (CAS 67-63-0) were investigated.
     </p>
    </div>
    <div id="sec-8" class="subsection">
     <h3>Quantitative Suspension Test and Virus Titration</h3>
     <p id="p-14">Virucidal activity studies were performed with a quantitative suspension test with 30 seconds exposure time
      <sup>
       <a id="xref-ref-3-3" class="xref-bibr" href="#ref-3">3</a>
      </sup>. Briefly, one part virus suspension was mixed with one part organic load (0.3 % bovine serum albumin [BSA] as interfering substance) and eight parts disinfection solution of different concentrations. Following 30 seconds exposure, samples were serially diluted and the TCID50/mL values were determined by crystal violet staining and subsequent scoring the amounts of wells displaying cytopathic effects. TCID
      <sub>50</sub> is calculated by the Spearman &amp;; Kärber algorithm as described
      <sup>
       <a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>
      </sup>. Cytotoxic effects of disinfectants were monitored by crystal violet staining and optical analysis for altered density and morphology of the cellular monolayer in the absence of virus and were quantified analogous to the TCID
      <sub>50</sub>/mL of the virus infectivity.
     </p>
    </div>
    <div id="sec-9" class="subsection">
     <h3>Statistical Analysis</h3>
     <p id="p-15">Dose-response curves (normalized virus inactivation [%] 
      <em>vs</em>. log (disinfectant concentration [%]) were determined using nonlinear regression using the robust fitting method on the normalized 50 % tissue culture infectious dose (TCID
      <sub>50</sub>) data implemented in GraphPad Prism version 8.0.3 for Windows. Reference curves for SARS-CoV, MERS-CoV and BCoV were plotted based on previously published data
      <sup>
       <a id="xref-ref-6-2" class="xref-bibr" href="#ref-6">6</a>
      </sup>. The mean TCID50 and standard deviations of means were assessed from 2-3 individual experiments. Outlier were identified using Grubb’s test (GraphPad Prism). Reduction factors (RF) for each treatment condition were calculated as follows: 
      <span class="disp-formula" id="disp-formula-1">
       <span class="highwire-responsive-lazyload">
        <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.biorxiv.org/sites/default/files/highwire/biorxiv/early/2020/03/17/2020.03.10.986711/embed/graphic-3.gif"/>
        <noscript>
         <img class="highwire-embed" alt="Embedded Image" src="https://www.biorxiv.org/sites/default/files/highwire/biorxiv/early/2020/03/17/2020.03.10.986711/embed/graphic-3.gif"/>
        </noscript>
       </span>
      </span>
     </p>
    </div>
   </div>
   <div class="section ack" id="ack-1">
    <h2 class="">Acknowledgments</h2>
    <p id="p-16">We would like to thank all members of Institute of Virology and Immunology, Bern and the Department for Molecular &amp;; Medical Virology for helpful suggestions and discussions.</p>
   </div>
   <div class="section fn-group" id="fn-group-1">
    <h2>Footnotes</h2>
    <ul>
     <li class="fn-supported-by" id="fn-1">
      <p id="p-1">
       <strong>Financial support</strong>, This study was supported by the European Commission (Marie Sklodowska-Curie Innovative Training Network “HONOURS”; grant agreement No 721367), and by the Federal Ministry of Education and Research, Germany (BMBF; grant RAPID, #01KI1723A).
      </p>
     </li>
     <li class="fn-conflict" id="fn-2">
      <p id="p-2">Conflict of interest: The authors do not have a conflict of interest.</p>
     </li>
    </ul>
   </div>
   <div class="section ref-list" id="ref-list-1">
    <h2 class="">References</h2>
    <ol class="cit-list ref-use-labels">
     <li>
      <span class="ref-label">1.</span>
      <a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text" id="ref-1">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.10.986711v1.1" data-doi="10.1056/NEJMoa030747">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Drosten</span>
          <span class="cit-name-given-names">C</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Günther</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Preiser</span>
          <span class="cit-name-given-names">W</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Identification of a novel coronavirus in patients with severe acute respiratory syndrome</span>. 
         <abbr class="cit-jnl-abbrev">N Engl J Med</abbr>. 
         <span class="cit-pub-date">2003</span>;
         <span class="cit-vol">348</span>(
         <span class="cit-issue">20</span>):
         <span class="cit-fpage">1967</span>–
         <span class="cit-lpage">1976</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1056/NEJMoa030747</span>
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa030747%26rft_id%253Dinfo%253Apmid%252F12690091%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1056/NEJMoa030747&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=12690091&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F17%2F2020.03.10.986711.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
        <a href="/lookup/external-ref?access_num=000182823400005&amp;;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
         <span>Web of Science</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">2.</span>
      <a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text" id="ref-2">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.10.986711v1.2" data-doi="10.1056/NEJMoa1211721">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Zaki</span>
          <span class="cit-name-given-names">AM</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">van Boheemen</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Bestebroer</span>
          <span class="cit-name-given-names">TM</span>
         </span>, 
         <span class="cit-article-title">Osterhaus ADME, Fouchier RAM. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia</span>. 
         <abbr class="cit-jnl-abbrev">N Engl JMed</abbr>. 
         <span class="cit-pub-date">2012</span>;
         <span class="cit-vol">367</span>(
         <span class="cit-issue">19</span>):
         <span class="cit-fpage">1814</span>–
         <span class="cit-lpage">1820</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1056/NEJMoa1211721</span>
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DZaki%26rft.auinit1%253DA.%2BM.%26rft.volume%253D367%26rft.issue%253D19%26rft.spage%253D1814%26rft.epage%253D1820%26rft.atitle%253DIsolation%2Bof%2Ba%2Bnovel%2Bcoronavirus%2Bfrom%2Ba%2Bman%2Bwith%2Bpneumonia%2Bin%2BSaudi%2BArabia.%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1211721%26rft_id%253Dinfo%253Apmid%252F23075143%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1056/NEJMoa1211721&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
        <a href="/lookup/external-ref?access_num=23075143&amp;;link_type=MED&amp;;atom=%2Fbiorxiv%2Fearly%2F2020%2F03%2F17%2F2020.03.10.986711.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
         <span>PubMed</span>
        </a>
        <a href="/lookup/external-ref?access_num=000310773200008&amp;;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
         <span>Web of Science</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">3.</span>
      <a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text" id="ref-3">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.10.986711v1.3" data-doi="10.1086/600379">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth cit-collab">WHO(b)</span>. 
         <span class="cit-article-title">WHO Guidelines on Hand Hygiene in Health Care</span>. 
         <abbr class="cit-jnl-abbrev">World Health</abbr>. 
         <span class="cit-pub-date">2009</span>;
         <span class="cit-vol">30</span>(
         <span class="cit-issue">1</span>):
         <span class="cit-fpage">270</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1086/600379</span>
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DWorld%2BHealth%26rft.volume%253D30%26rft.spage%253D270%26rft_id%253Dinfo%253Adoi%252F10.1086%252F600379%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1086/600379&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">4.</span>
      <a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text" id="ref-4">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.10.986711v1.4" data-doi="10.1016/j.ijantimicag.2020.105924">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Lai</span>
          <span class="cit-name-given-names">C-C</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Shih</span>
          <span class="cit-name-given-names">T-P</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Ko</span>
          <span class="cit-name-given-names">W-C</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Tang</span>
          <span class="cit-name-given-names">H-J</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Hsueh</span>
          <span class="cit-name-given-names">P-R.</span>
         </span>
         <span class="cit-article-title">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges</span>. 
         <abbr class="cit-jnl-abbrev">Int J Antimicrob Agents</abbr>. 
         <span class="cit-pub-date">2020</span>:
         <span class="cit-fpage">105924</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1016/j.ijantimicag.2020.105924</span>
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DInt%2BJ%2BAntimicrob%2BAgents%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.ijantimicag.2020.105924%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1016/j.ijantimicag.2020.105924&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">5.</span>
      <a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text" id="ref-5">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.10.986711v1.5">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth cit-collab">CSSE Johns Hopkins</span>. 
         <abbr class="cit-jnl-abbrev">Coronavirus COVID-19 Global Cases</abbr>.
        </cite>
       </div>
       <div class="cit-extra"/>
      </div>
     </li>
     <li>
      <span class="ref-label">6.</span>
      <a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text" id="ref-6">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.10.986711v1.6" data-doi="10.1093/infdis/jix046">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Siddharta</span>
          <span class="cit-name-given-names">A</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Pfaender</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Vielle</span>
          <span class="cit-name-given-names">NJ</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Virucidal activity of world health organization-recommended formulations against enveloped viruses, including zika, ebola, and emerging coronaviruses</span>. 
         <abbr class="cit-jnl-abbrev">J Infect Dis</abbr>. 
         <span class="cit-pub-date">2017</span>;
         <span class="cit-vol">215</span>(
         <span class="cit-issue">6</span>):
         <span class="cit-fpage">902</span>–
         <span class="cit-lpage">906</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1093/infdis/jix046</span>
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DJ%2BInfect%2BDis%26rft.volume%253D215%26rft.spage%253D902%26rft_id%253Dinfo%253Adoi%252F10.1093%252Finfdis%252Fjix046%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1093/infdis/jix046&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">7.</span>
      <a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7. in text" id="ref-7">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.10.986711v1.7" data-doi="10.1016/j.jhin.2020.01.022">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Kampf</span>
          <span class="cit-name-given-names">G</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Todt</span>
          <span class="cit-name-given-names">D</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Pfaender</span>
          <span class="cit-name-given-names">S</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Steinmann</span>
          <span class="cit-name-given-names">E.</span>
         </span>
         <span class="cit-article-title">Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents</span>. 
         <abbr class="cit-jnl-abbrev">J Hosp Infect</abbr>. 
         <span class="cit-pub-date">2020</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1016/j.jhin.2020.01.022</span>
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DJ%2BHosp%2BInfect%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jhin.2020.01.022%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1016/j.jhin.2020.01.022&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">8.</span>
      <a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text" id="ref-8">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.10.986711v1.8" data-doi="10.1186/s13756-017-0271-3">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Becker</span>
          <span class="cit-name-given-names">B</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Brill</span>
          <span class="cit-name-given-names">FHH</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Todt</span>
          <span class="cit-name-given-names">D</span>
         </span>, 
         <span class="cit-etal">et al.</span>
         <span class="cit-article-title">Virucidal efficacy of peracetic acid for instrument disinfection</span>. 
         <abbr class="cit-jnl-abbrev">Antimicrob Resist Infect Control</abbr>. 
         <span class="cit-pub-date">2017</span>;
         <span class="cit-vol">6</span>(
         <span class="cit-issue">1</span>).
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1186/s13756-017-0271-3</span>
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DAntimicrob%2BResist%2BInfect%2BControl%26rft_id%253Dinfo%253Adoi%252F10.1186%252Fs13756-017-0271-3%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1186/s13756-017-0271-3&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
     <li>
      <span class="ref-label">9.</span>
      <a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text" id="ref-9">↵</a>
      <div class="cit ref-cit ref-journal" id="cit-2020.03.10.986711v1.9" data-doi="10.1016/B978-012465330-6/50003-8">
       <div class="cit-metadata">
        <cite>
         <span class="cit-auth">
          <span class="cit-name-surname">Places</span>
          <span class="cit-name-given-names">G</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Hierholzer</span>
          <span class="cit-name-given-names">JC</span>
         </span>, 
         <span class="cit-auth">
          <span class="cit-name-surname">Killington</span>
          <span class="cit-name-given-names">RA.</span>
         </span>
         <span class="cit-article-title">Cell Culture Cell Culture</span>. 
         <abbr class="cit-jnl-abbrev">Virol Methods Man</abbr>. 
         <span class="cit-pub-date">1996</span>;
         <span class="cit-vol">76</span>(
         <span class="cit-issue">1</span>):
         <span class="cit-fpage">2</span>–
         <span class="cit-lpage">6</span>.
         <span class="cit-pub-id-sep cit-pub-id-doi-sep"> </span>
         <span class="cit-pub-id-scheme">doi:</span>
         <span class="cit-pub-id cit-pub-id-doi">10.1016/B978-012465330-6/50003-8</span>
        </cite>
       </div>
       <div class="cit-extra">
        <a href="{openurl}?query=rft.jtitle%253DVirol%2BMethods%2BMan%26rft_id%253Dinfo%253Adoi%252F10.1016%252FB978-012465330-6%252F50003-8%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
         <span>OpenUrl</span>
        </a>
        <a href="/lookup/external-ref?access_num=10.1016/B978-012465330-6/50003-8&amp;;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
         <span>CrossRef</span>
        </a>
       </div>
      </div>
     </li>
    </ol>
   </div>
   <span class="highwire-journal-article-marker-end"/>
  </div>
 </body>
</html>
